OS Therapies Incorporated (OSTX) - Cekelan dhuwit saben saham

OS Therapies, Inc. - logo grafis emiten OSTX

An analysis of cash per share demonstrates the implementation of automation in OS Therapies Incorporated (OSTX) laboratories to accelerate cancer screening, with the 0.01 mark recording this metric. The growth in business value is supported by FDA Fast Track designations and merger potential. The company's environmental strategy is based on chemical recycling and wastewater treatment to minimize ecological impact.

OS Therapies (OSTX) - Dhuwit awis saben saham saka 02.08.2024 nganti 20.11.2026

Rincian metrik komprehensif lan analitis OS Therapies Inc. (OSTX)

- indikator anane dhuwit lan arus kas:
Ringkesan analisis perusahaan:OSTX (OS Therapies, Inc.)
Produk sing diprodhuksi OS Therapies

Cash per share determines the portion of liquid assets attributable to a single security. Investors utilize this metric to assess financial stability and a company's ability to fund operational activities without external borrowing. By analyzing the cash per share ratio, one can evaluate the issuer's margin of safety. For OS Therapies Incorporated (OSTX), this reserve is critically important during the conduct of OST-HER2 trials. Liquidity ensures the development of orphan drugs in an environment lacking market competition.

Analisis perusahaan pesaing

Dana dhuwit saben siji saham ONC (BeiGene Corp)|Dhuwit awis saben siji saham HALO (Halozyme Therapeutics, Inc.)|Dhuwit awis saben saham Revolution Medicines, Inc. (RVMD)|Dhuwit awis saben saham AAPG (ascentage.com)|CG Oncology Inc (CGON) - Cekelan dhuwit saben saham|URGN - Dana dhuwit saben saham|Bicara Bio - Dhuwit awis diétung saben siji saham|PSNL: Dhuwit awis saben saham|Dana dhuwit saben siji saham ERAS|Dhuwit awis saben siji saham DCTH|Cekelan dhuwit saben saham Y-mAbs Therapeutics Inc YMAB|Dhuwit awis saben saham AURA|CADL (Candel Therapeutics, Inc.) - Gunggung dhuwit awis saben saham|Dana dhuwit saben saham Accuray Inc ARAY|Dana dhuwit diétung saben saham SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Dhuwit awis saben saham|Cekelan dhuwit saben saham Citius Oncology|HURA: Dhuwit awis saben saham|Dhuwit awis saben lembar saham TARA (Protara)|FATE (fatetherapeutics.com) - Dhuwit awis saben saham|Cekelan dhuwit saben saham Aadi Bioscience WHWK|Dhuwit awis saben saham TCRX|CSBR - Cekelan dhuwit saben saham|XBiotech - Dhuwit awis saben siji saham|CEL-SCI Corporation (CVM) - Cekelan dhuwit saben saham|RADX - Dana dhuwit saben saham|ARTV - Dhuwit awis saben saham|Adlai Nortye Ltd (ANL) - Dana dhuwit saben saham|Veru Pharma - Gunggung dhuwit awis saben saham|Dana dhuwit saben saham Tempest Therapeutics Corp|Dana dhuwit saben siji saham XLO (Xilio Therapeutics, Inc.)|Dhuwit awis saben saham RENB|MURA (Mural Oncology) - Gunggung dhuwit awis saben saham|Dhuwit awis saben saham KAPA (Kairos Pharma Ltd)|OKUR: Dana dhuwit saben siji saham|GDTC: Dhuwit awis saben siji saham|CRIS - Dhuwit awis saben saham|APLM: Dhuwit awis saben saham|Cekelan dhuwit saben saham tharimmune.com (THAR)|ADVB (Advanced Biomed Corp) - Dhuwit awis saben saham|Dhuwit awis saben saham Genprex Inc.|Dhuwit awis saben saham CLDI|Dhuwit awis saben siji saham Sunshine Biopharma, Inc. SBFM|Dhuwit awis saben saham XBIO (Xenetic Biosciences)|Gunggung dhuwit awis saben saham SLRX|PPBT - Dana dhuwit saben saham|AONC (aoncology.com) - Dana dhuwit saben siji saham|BGNE: Dhuwit awis saben saham|Checkpoint Therapeutics Inc (CKPT) - Dhuwit awis saben saham|ELEV (Elevation Oncology Inc.) - Dhuwit awis saben saham|icadmed.com (ICAD) - Dana dhuwit diétung saben saham|Dhuwit awis saben saham IKNA|NTBL (Notable Labs) - Gunggung dhuwit awis saben saham|Dhuwit awis saben saham VIRX (Viracta Therapeutics)|Dana dhuwit diétung saben saham MorphoSys AG (MOR)|NAYA Biosciences Corp - Dhuwit awis saben saham|Cekelan dhuwit saben saham ascentage.com